FIELD: chemistry.
SUBSTANCE: invention relates to a compound by the formula (Ia)
and to an application thereof for producing a medicinal product for treating cancer mediated by inhibition of cytosolic thioredoxin reductase.
EFFECT: creation of a compound applicable in treating cancer.
13 cl, 12 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN TREATMENT OF CANCER | 2018 |
|
RU2777596C2 |
| PYRIDINES AND USE THEREOF IN TREATING CANCER | 2016 |
|
RU2730505C2 |
| SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
| TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING CANCER | 2016 |
|
RU2736501C2 |
| 3,4-DIHYDROISOQUINOLINE COMPOUND AND USE THEREOF | 2021 |
|
RU2825312C1 |
| 1,3,5-TRIAZINE DERIVATIVE AND A METHOD FOR USE THEREOF | 2016 |
|
RU2724333C2 |
| LOW-MOLECULAR INHIBITORS OF N-TERMINUS ACTIVATION OF ANDROGEN RECEPTOR | 2009 |
|
RU2519948C2 |
| BENZAZEPINE COMPOUNDS, CONJUGATES AND THEIR USE | 2018 |
|
RU2780334C2 |
| CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES | 2016 |
|
RU2732405C2 |
| N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
